Revvity Inc PKI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PKI is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- €1,701.71 / €1,816.09
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 21.93
- Price/Sales
- 4.63
- Dividend Yield (Trailing)
- 0.21%
- Dividend Yield (Forward)
- 3.34%
- Total Yield
- 0.73%
Company Profile
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Core
- Total Number of Employees
- 11,500
- Website
- https://www.revvity.com
Competitors
Valuation
|
Metric
|
PKI
|
WAT
|
TMO
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.93 | 27.75 | 26.50 |
Price/Book Value | 2.10 | 15.39 | 4.80 |
Price/Sales | 4.63 | 6.65 | 5.22 |
Price/Cash Flow | 20.86 | 23.44 | 25.55 |
Price/Earnings
PKI
WAT
TMO
Financial Strength
|
Metric
|
PKI
|
WAT
|
TMO
|
|---|---|---|---|
Quick Ratio | 1.66 | 1.39 | 1.19 |
Current Ratio | 2.23 | 2.22 | 1.70 |
Interest Coverage | 2.01 | 8.28 | 4.83 |
Quick Ratio
PKI
WAT
TMO
Profitability
|
Metric
|
PKI
|
WAT
|
TMO
|
|---|---|---|---|
Return on Assets (Normalized) | 1.87% | 17.19% | 8.69% |
Return on Equity (Normalized) | 3.30% | 88.59% | 18.71% |
Return on Invested Capital (Normalized) | 2.26% | 25.75% | 10.97% |
Return on Assets
PKI
WAT
TMO
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Kqdwpymqw | Qknkt | $218.7 Bil | |
DHR
| Danaher Corp | Sjsgynmpt | Hztcr | $184.3 Bil | |
IQV
| IQVIA Holdings Inc | Jxpjxjtn | Xdswj | $41.7 Bil | |
A
| Agilent Technologies Inc | Krlwjqrl | Sht | $41.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Jbhfpfcwvz | Xdkqf | $39.9 Bil | |
MTD
| Mettler-Toledo International Inc | Bzwwhjcvxy | Dysbcl | $26.7 Bil | |
ICLR
| Icon PLC | Cxfgnkhs | Tbdzygw | $26.0 Bil | |
WAT
| Waters Corp | Rygvqtknv | Mxyp | $19.3 Bil | |
ILMN
| Illumina Inc | Qnhkbry | Thgkt | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Tkrhsdyvg | Wzxlg | $17.0 Bil |